Pacagen

🗓 Founded 2023👥 29 employees💰 Last funded Apr 2025
Pacagen creates cutting-edge, science-backed products that help thousands of families conquer cat, dog, and dust mite allergens. Our mission is simple: we want to equip you with the tools to fight back against allergens and reclaim your comfort, cuddles, and wellbeing, in every space you call home. The Pacagen approach is powerful because it doesnt rely on changing how the immune system behaves. Traditional allergy medications wait for your body to react and then tries to calm it down. Pacagen works differently. Our products neutralize allergens at the molecular level before they ever reach your system. The result? Less sneezing, less irritation, no side effects, and full control.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Pacagen?
Pacagen has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Pacagen last raise funding?
The most recent investment in Pacagen recorded on gritt.io was in April 2025.
When was Pacagen founded?
Pacagen was founded in 2023.
What industry is Pacagen in?
Pacagen operates in Pet Services. Find similar Pet Services investors on gritt.io.